Bibliography
Found 251 results
Filters: Keyword is Male [Clear All Filters]
Higher Anti-Cytomegalovirus Immunoglobulin G Concentrations Are Associated With Worse Neurocognitive Performance During Suppressive Antiretroviral Therapy. Clin Infect Dis. 2018 ;67(5):770-777.
Human immunodeficiency virus type 1 (HIV-1)-mediated neuroinflammation dysregulates neurogranin and induces synaptodendritic injury. J Neuroinflammation. 2018 ;15(1):126.
. Impact of Antiretroviral Regimens on Cerebrospinal Fluid Viral Escape in a Prospective Multicohort Study of Antiretroviral Therapy-Experienced Human Immunodeficiency Virus-1-Infected Adults in the United States. Clin Infect Dis. 2018 ;67(8):1182-1190.
. Motor function declines over time in human immunodeficiency virus and is associated with cerebrovascular disease, while HIV-associated neurocognitive disorder remains stable. J Neurovirol. 2018 ;24(4):514-522.
. Multivariate Pattern Analysis of Volumetric Neuroimaging Data and Its Relationship With Cognitive Function in Treated HIV Disease. J Acquir Immune Defic Syndr. 2018 ;78(4):429-436.
. Neurocognitive functioning predicts frailty index in HIV. Neurology. 2018 ;91(2):e162-e170.
. A neuropathologic diagnosis of Alzheimer's disease in an older adult with HIV-associated neurocognitive disorder. Neurocase. 2018 ;24(4):213-219.
. No reliable gene expression biomarkers of current or impending neurocognitive impairment in peripheral blood monocytes of persons living with HIV. J Neurovirol. 2018 ;24(3):350-361.
OAS Gene Family Expression Is Associated with HIV-Related Neurocognitive Disorders. Mol Neurobiol. 2018 ;55(3):1905-1914.
. Relationship between brain large artery characteristics and their downstream arterioles. J Neurovirol. 2018 ;24(1):106-112.
. Sex differences in HIV-associated cognitive impairment. AIDS. 2018 ;32(18):2719-2726.
. The Spleen Is an HIV-1 Sanctuary During Combined Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2018 ;34(1):123-125.
. The Use of Visual Rating Scales to Quantify Brain MRI Lesions in Patients with HIV Infection. J Neuroimaging. 2018 ;28(2):217-224.
. Age of Last Alcohol Use Disorder Relates to Processing Speed Among Older Adults Living with HIV. Alcohol Alcohol. 2019 ;54(2):139-147.
. Associations of regional amyloid-β plaque and phospho-tau pathology with biological factors and neuropsychological functioning among HIV-infected adults. J Neurovirol. 2019 ;25(6):741-753.
. Benzodiazepine Use Is Associated With an Increased Risk of Neurocognitive Impairment in People Living With HIV. J Acquir Immune Defic Syndr. 2019 ;82(5):475-482.
. Better executive function is independently associated with full HIV suppression during combination therapy. AIDS. 2019 ;33(15):2309-2316.
. Caspase-1 Activation Is Related With HIV-Associated Atherosclerosis in an HIV Transgenic Mouse Model and HIV Patient Cohort. Arterioscler Thromb Vasc Biol. 2019 ;39(9):1762-1775.
Catechol-O-methyltransferase polymorphism Val158Met is associated with distal neuropathic pain in HIV-associated sensory neuropathy. AIDS. 2019 ;33(10):1575-1582.
. CCR2 on Peripheral Blood CD14CD16 Monocytes Correlates with Neuronal Damage, HIV-Associated Neurocognitive Disorders, and Peripheral HIV DNA: reseeding of CNS reservoirs?. J Neuroimmune Pharmacol. 2019 ;14(1):120-133.
Cerebrospinal Fluid Ceruloplasmin, Haptoglobin, and Vascular Endothelial Growth Factor Are Associated with Neurocognitive Impairment in Adults with HIV Infection. Mol Neurobiol. 2019 ;56(5):3808-3818.
Cerebrospinal fluid extracellular vesicles and neurofilament light protein as biomarkers of central nervous system injury in HIV-infected patients on antiretroviral therapy. AIDS. 2019 ;33(4):615-625.
. Cerebrospinal fluid viral escape in aviremic HIV-infected patients receiving antiretroviral therapy: prevalence, risk factors and neurocognitive effects. AIDS. 2019 ;33(3):475-481.
Chronic Distal Sensory Polyneuropathy Is a Major Contributor to Balance Disturbances in Persons Living With HIV. J Acquir Immune Defic Syndr. 2019 ;80(5):568-573.
. Cognitive Trajectory Phenotypes in Human Immunodeficiency Virus-Infected Patients. J Acquir Immune Defic Syndr. 2019 ;82(1):61-70.
.